{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-047260","form_type":"8-K","ticker":"RNLXY","cik":"0001811115","company_name":"Renalytix plc","filed_at":"2023-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.356837+00:00","generated_at":"2026-06-10T22:17:21.287606+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Renalytix appoints Howard Doran as Chief Business Officer to lead KidneyIntelX sales","bullets":["Howard Doran appointed Chief Business Officer effective Sept 1, 2023, to lead KidneyIntelX global sales.","Doran brings 30+ yrs diagnostics exp; served as CEO of LipoScience (acquired by LabCorp) and President of Hologic Global Diagnostics.","Annual base salary of $300,000; target bonus 60% of base; options for 300,000 ordinary shares with 3-yr vesting and 1-yr cliff.","Renalytix commercializes FDA-approved AI prognostic blood test for type 2 diabetes and chronic kidney disease."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-047260","json":"https://secwatch.observer/filing/0000950170-23-047260.json","markdown":"https://secwatch.observer/filing/0000950170-23-047260.md","text":"https://secwatch.observer/filing/0000950170-23-047260.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023047260/0000950170-23-047260-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023047260/rnlx-20230901.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:17:21.287606+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"298c3d07a2","claim":"Howard Doran Jr. was appointed as Chief Business Officer at Renalytix plc.","evidence_excerpt":"On September 1, 2023, the Company’s Board of Directors appointed Howard Doran Jr. as the Company’s Chief Business Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1811115/000095017023047260/0000950170-23-047260-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}